Progen Matériel de laboratoire
MSH6 (RBT-MSH6), RMab

MSH6 (RBT-MSH6), RMab

MSH6 (RBT-MSH6), rabbit monoclonal antibody, is a primary antibody intended for laboratory use by trained laboratory personnel in an immunohistochemical (IHC) assay to qualitatively identify the MSH6 protein by light microscopy in normal and/or pathological formalin-fixed, paraffin-embedded (FFPE) human tissue. The clinical interpretation of any staining or its absence should be performed by a qualified pathologist and complemented by morphological studies using proper controls and evaluated within the context of the patient’s clinical history and other diagnostic tests.

Clone RBT-MSH6 IgG Rabbit Monoclonal

Description

MSH6, also known as mutS homolog 6, is a gene commonly associated with Hereditary Non-Polyposis Colorectal Cancer (HNPCC). HNPCC is an autosomal, dominantly inherited disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early onset Colorectal Carcinoma and extra-colonic cancers of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited Colorectal Cancer in the western world. MSH6 is a mismatch repair gene which is deficient in a high proportion of patients with microsatellite instability (MSI-H). The anti-MSH6 antibody is useful in screening patients and families for HNPCC. Colon cancers that are microsatellite-unstable have a better prognosis than their microsatellite-stable counterpart.

Synonymes

TFF3, trefoil factor 3 intestinal, ITF, P1B, TFI, anti-tff3, anti-itf

Caractéristiques

Type
Rabbit Monoclonal
Clone
RBT-MSH6
Isotype
IgG
Réactivité
Human
Localisation
Nuclear
Usage prévu
MSH6 (RBT-MSH6), rabbit monoclonal antibody, is a primary antibody intended for laboratory use by trained laboratory personnel in an immunohistochemical (IHC) assay to qualitatively identify the MSH6 protein by light microscopy in normal and/or pathological formalin-fixed, paraffin-embedded (FFPE) human tissue. The clinical interpretation of any staining or its absence should be performed by a qualified pathologist and complemented by morphological studies using proper controls and evaluated within the context of the patient’s clinical history and other diagnostic tests.

Intéressé par ce produit ?

Indiquez la référence et le conditionnement souhaités, nous revenons vers vous rapidement.

Demander un devis